The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of patients at high risk for relapse by Merlin assay (CP-GEP) in an independent cohort of melanoma patients (pts) that did not undergo sentinel lymph node biopsy: An H&N subgroup analysis.
 
Teresa Amaral
Consulting or Advisory Role - CeCaVa; Delcath Systems; Medscape; Menarini; NeraCare GmbH; Novartis; Philogen; Pierre Fabre
Research Funding - Agenus (Inst); AstraZeneca (Inst); BioNTech SE (Inst); Biotech IOB (Inst); BMS GmbH & Co. KG (Inst); HUYA Bioscience International (Inst); Immunocore (Inst); MSD (Inst); NeraCare GmbH (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Regeneron (Inst); Replimune (Inst); Roche/Genentech (Inst); Sanofi Aventis GmbH (Inst); Skyline Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - 18/384,708 ErbB-MEL ("EGFR")
Travel, Accommodations, Expenses - NeraCare GmbH
 
Eftychia Chatziioannou
No Relationships to Disclose
 
Alica Nuebling
No Relationships to Disclose
 
Tobias Sinnberg
No Relationships to Disclose
 
Heike Niessner
No Relationships to Disclose
 
Ulrike Leiter
Honoraria - MSD Oncology; Novartis; Roche; Sanofi; Sun Pharma
Consulting or Advisory Role - MSD Oncology; Novartis; Roche; Sanofi; Sun Pharma
Research Funding - MSD Oncology
Travel, Accommodations, Expenses - Novartis
 
Djvalini Dwarkasing
Employment - Skyline Diagnostics
 
Tim Arentsen
Employment - Skyline Diagnostics; Skyline Diagnostics
 
Christian Groß
Employment - Skyline Diagnostics
 
Alexander Eggermont
Stock and Other Ownership Interests - IO Biotech; Sairopa; SkyllineDx
Honoraria - Agenus; Bioinvent; BioNTech; Boehringer Ingelheim; Brenus Pharma; Catalym; Genoway; GlaxoSmithKline; Imcheck Therapeutics; IO Biotech; ISA Pharmaceuticals; Merck; MSD; Pfizer; Regeneron; Scorpion Therapeutics; Sellas Life Sciences; Trained Tmmunity Discovery
Consulting or Advisory Role - Agenus; Bioinvent; BioNTech; Boehringer Ingelheim; Brenus Pharma; Catalym; Genoway; GlaxoSmithKline; Imcheck Therapeutics; IO Biotech; ISA Pharmaceuticals; Merck; MSD; Pfizer; Regeneron; Scorpion Therapeutics; Sellas Life Sciences; trained immunity discovery
Speakers' Bureau - Merck; MSD
 
Lukas Flatz
Consulting or Advisory Role - Philogen; Sanofi
Research Funding - Hookipa Pharma; Philogen
Patents, Royalties, Other Intellectual Property - 18/384,708 ErbB-MEL (; Patents relating to the Vaxwave Vaccine Technology currently licensed by Hookipa Pharma
 
Stephan Forchhammer
Honoraria - Recordati
Research Funding - BioNTech SE (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)